Orion Corporation and CuraTeQ announce expansion to biosimilars deal

Jan 11, 2022

Orion Corporation and CuraTeQ Biologics announced an expansion to their biosimilar distribution agreement in Europe to include the Baltic countries.  All products under the agreement are still in development or regulatory phases, with launches estimated to take place in 2023-2026.

Print Page Mail Article